Mapping brain metabolism, connectivity and neurotransmitters topography in early and late onset dementia with lewy bodies

Parkinsonism Relat Disord. 2024 May:122:106061. doi: 10.1016/j.parkreldis.2024.106061. Epub 2024 Feb 27.

Abstract

Introduction: Early-onset dementia with Lewy bodies (EO-DLB) is associated with rapid cognitive decline and severe neuropsychiatric symptoms at onset.

Methods: Using FDG-PET imaging for 62 patients (21 EO-DLB, 41 LO (late-onset)-DLB), we explored brain hypometabolism, and metabolic connectivity in the whole-brain network and resting-state networks (RSNs). We also evaluated the spatial association between brain hypometabolism and neurotransmitter pathways topography.

Results: Direct comparisons between the two clinical subgroups showed that EO-DLB was characterized by a lower metabolism in posterior cingulate/precuneus and occipital cortex. Metabolic connectivity analysis revealed significant alterations in posterior regions in both EO-DLB and LO-DLB. The EO-DLB, however, showed more severe loss of connectivity between occipital and parietal nodes and hyperconnectivity between frontal and cerebellar nodes. Spatial topography association analysis indicated significant correlations between neurotransmitter maps (i.e. acetylcholine, GABA, serotonin, dopamine) and brain hypometabolism in both EO and LO-DLB, with significantly higher metabolic correlation in the presynaptic serotonergic system for EO-DLB, supporting its major dysfunction.

Conclusions: Our study revealed greater brain hypometabolism and loss of connectivity in posterior brain region in EO- than LO-DLB. Serotonergic mapping emerges as a relevant factor for further investigation addressing clinical differences between DLB subtypes.

Keywords: Brain metabolism; Connectivity; Disease onset; Lewy body disease; Serotonin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Brain Mapping
  • Brain* / diagnostic imaging
  • Brain* / metabolism
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Lewy Body Disease* / diagnostic imaging
  • Lewy Body Disease* / metabolism
  • Male
  • Middle Aged
  • Nerve Net / diagnostic imaging
  • Nerve Net / metabolism
  • Neural Pathways / diagnostic imaging
  • Neural Pathways / metabolism
  • Neurotransmitter Agents* / metabolism
  • Positron-Emission Tomography*

Substances

  • Neurotransmitter Agents
  • Fluorodeoxyglucose F18